Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Clappy who wrote (2197)	5/23/2002 9:28:28 PM
From: Gary Stern	Respond to of 2205

The concept of "Pumping" has nothing to do with public relations. This company has an inventory of patents that is extraordinary. Sales by Biozhem bear a royalty that has been accruing; yet, none of us has idea as to the amount. Have you ever seen the presentations that company's make to analysts. Why are there NO analysts covering this issue when it is the leader amongst "Tissue Engineering Stocks". Why does virtually no one even know about tissue engineering? Its because this company has done a woeful job in education the Street and the public. This company has something to sell without being accused of "Pumping".